Literature DB >> 3630537

Aspirin and non-enzymatic glycation.

A Ceriello, D Giugliano, A Quatraro, A Stante.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3630537     DOI： 10.1007/BF02742856

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN： 0001-5563


× No keyword cloud information.
  11 in total

1.  Aspirin, nifedipine, and cataract.

Authors: 
Journal:  Lancet       Date:  1986-07-05       Impact factor: 79.321

2.  Do aspirin-like analgesics protect against cataract? A case-control study.

Authors:  R van Heyningen; J J Harding
Journal:  Lancet       Date:  1986-05-17       Impact factor: 79.321

3.  Aspirin-like analgesics and cataract.

Authors:  J J Harding; R van Heyningen
Journal:  Lancet       Date:  1986-11-01       Impact factor: 79.321

4.  Non-enzymatic glycosylation reduces antithrombin III activity.

Authors:  A Ceriello; F Curcio; P Dello Russo; D Giugliano
Journal:  Thromb Haemost       Date:  1984-12-29       Impact factor: 5.249

5.  Decreased antithrombin III activity in diabetes may be due to non-enzymatic glycosylation--a preliminary report.

Authors:  A Ceriello; P Dello Russo; C Zuccotti; A Florio; S Nazzaro; C Pietrantuono; G B Rosato
Journal:  Thromb Haemost       Date:  1983-10-31       Impact factor: 5.249

6.  Inhibition of heparin-catalyzed human antithrombin III activity by nonenzymatic glycosylation. Possible role in fibrin deposition in diabetes.

Authors:  M Brownlee; H Vlassara; A Cerami
Journal:  Diabetes       Date:  1984-06       Impact factor: 9.461

7.  Metabolic control may alter antithrombin III activity but not its plasma concentration in diabetes: a possible role for nonenzymatic glycosylation.

Authors:  A Ceriello; D Giugliano; P Dello Russo; A Tirelli; N Passariello; S Sgambato
Journal:  Diabetes Care       Date:  1986 Jan-Feb       Impact factor: 19.112

8.  Daily rapid blood glucose variations may condition antithrombin III biologic activity but not its plasma concentration in insulin-dependent diabetes. A possible role for labile non-enzymatic glycation.

Authors:  A Ceriello; D Giugliano; A Quatraro; A Stante; G Consoli; P Dello Russo; F D'Onofrio
Journal:  Diabete Metab       Date:  1987-02

9.  Induced hyperglycemia alters antithrombin III activity but not its plasma concentration in healthy normal subjects.

Authors:  A Ceriello; D Giugliano; A Quatraro; G Consoli; A Stante; P Dello Russo; F D'Onofrio
Journal:  Diabetes       Date:  1987-03       Impact factor: 9.461

10.  Heparin preserves antithrombin III biological activity from hyperglycemia-induced alterations in insulin-dependent diabetics.

Authors:  A Ceriello; D Giugliano; A Quatraro; A Stante; G Consoli; P Dello Russo; F D'Onofrio
Journal:  Haemostasis       Date:  1986
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.